About CureMatch
CureMatch is a Healthcare company based in San Diego (United States) founded in 2015. CureMatch is focused on precision oncology solutions for cancer treatment. It operates on a HealthTech model. CureMatch offers products and services including Personalized Combination Therapy Analysis. Its focus areas include Oncology and Precision Medicine. Its legal entity is CureMatch, Inc. Its competitors include Denali Therapeutics, GRAIL, MiRagen, Color and Poseida Therapeutics and 3 more; 8 of its 8 listed competitors have raised funding.
Company details
CureMatch is engaged in providing precision oncology solutions through advanced technology. Personalized combination therapy analyses are offered to oncologists, leveraging genomic and proteomic data. The healthcare sector is primarily served, with a focus on cancer treatment customization. Proprietary algorithms and extensive data curation are utilized to rank and score treatment options. Collaboration with cancer centers, NGS labs, and concierge medicine providers is maintained to improve patient outcomes.
- Headquarters San Diego, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website curematch.com
- Social LinkedIn X Facebook
- Legal Name Curematch, Inc.
- InvestorsSerra Ventures
& 1 more
Products & Services of CureMatch
CureMatch offers a comprehensive portfolio of products and services, including Personalized Combination Therapy Analysis.
Personalized cancer treatment analysis is provided for oncologists.
Funding Insights of CureMatch
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of CureMatch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | – | Seed | – | – | |
| Oct 2015 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in CureMatch
CureMatch has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Serra Ventures and Analytics Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on Agtech and multiple sectors | – | serraventures.com | Champaign, United States | |
Analytics Ventures is involved in data-driven investment or technology. | – | analyticsventures.com | - |
Investor details for CureMatch
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CureMatch
34 people are tracked at CureMatch (7 in leadership, 24 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Sergey Kozhenkov | VP Of Software Engineering | Leadership |
Subha Krishnan | Director | Leadership |
Ally Perlina | Chief Science Officer (cso) | Leadership |
Navid Alipour | CEO | Leadership |
Emiliya Davtyan | Director Of Clinical Reporting | Leadership |
Sergei S. | Director of Engineering | Leadership |
Jose (Yosi) Oldak | Vice President Strategy | Leadership |
Patricia Lorusso | Advisor | Board & advisors |
Rick Stevens | Advisor | Board & advisors |
Blaise Barrelet | Chairman & Co-Founder | Board & advisors |
Greg Simon | Advisor | Board & advisors |
Ankur Bindal | Advisor | Board & advisors |
Jacob Adashek | Advisor | Board & advisors |
Kay Coleman | Advisor | Board & advisors |
Samantha Hasenleithner | Advisor | Board & advisors |
Jesse O’Gorman | Advisor | Board & advisors |
Gregory Horowitt | Advisor | Board & advisors |
Jordan Shlain | Advisor | Board & advisors |
David Szekeres | Advisor | Board & advisors |
Bob Kain | Advisor | Board & advisors |
14 more people are available in the full profile.
Complete people profiles for CureMatch
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CureMatch
3 dated milestones of CureMatch across 2 years, from founding to its latest funding, stage changes and deals.
- Founded CureMatch is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Competitors of CureMatch
CureMatch has 8 listed competitors in our database, 8 of them funded. They include Denali Therapeutics, GRAIL, MiRagen, Color and Poseida Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| unitybiotechnology.com | 2016 | San Francisco, United States | $206M | – | Therapeutics for aging diseases are developed by targeting senescent cells. |
Detailed competitors of CureMatch
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CureMatch
The website of CureMatch (curematch.com) receives about 3.1K visits a month and ranks #8,872,324 among all websites worldwide, #7,515 in Biotechnology and Pharmaceuticals.
- Monthly visits3.1K
▲ 82.2% vs previous month
- Global rank#8,872,324
among all websites
- Category rank#7,515
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.9
- Average visit46 sec
- DevicesDesktop 30% · Mobile 70%
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as CureMatch (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curematch
Complete news archive for CureMatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CureMatch
CureMatch was founded in 2015.
CureMatch is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
CureMatch is engaged in providing precision oncology solutions through advanced technology. Personalized combination therapy analyses are offered to oncologists, leveraging genomic and proteomic data. The healthcare sector is primarily served, with a focus on cancer treatment customization. Proprietary algorithms and extensive data curation are utilized to rank and score treatment options. Collaboration with cancer centers, NGS labs, and concierge medicine providers is maintained to improve patient outcomes.
CureMatch's top competitors include GRAIL, Juno Therapeutics and Poseida Therapeutics.
CureMatch offers Personalized Combination Therapy Analysis.
CureMatch has 2 investors. Key investors include Serra Ventures, and Analytics Ventures.
CureMatch operates through Curematch, Inc..